Ledger.Open graph →
SEC Form D · filed October 8, 2019

RELMADA THERAPEUTICS, INC

Offering
$826K
Sold
$826K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Paul Kelly · New York, NYDirectorCharles Casamento · New York, NYDirectorSergio Traversa · New York, NYExec · DirectorMaged Shenouda · New York, NYDirectorOttavio Vitolo · New York, NYExecHoward Davner · Freehold, NJExec · DirectorDanny Lin · SAN MATEO, CADirectorCorey B. Mulloy · Seattle, WADirectorRocco Lavista · Freehold, NJExecKevin Mcallister · BALTIMORE, MDDirectorChuck Ence · New York, NYExecChristopher Bentley · Spring, TXDirectorMason H. Resch · Chicago, ILDirectorTyler J. Resch · Chicago, ILDirectorJonpaul J. Jonkheer · Chicago, ILExec · DirectorDominic A. Bassani · Old Bethpage, NYExecChuck Ence · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗